El-Sayed H Ibrahim1, Elizabeth Gore1, Sherry-Ann Brown1, and Carmen Bergom2
1Medical College of Wisconsin, Milwaukee, WI, United States, 2Washington University, St Louis, MO, United States
Synopsis
Along with systemic therapies, radiation therapy
(RT) plays a key role in treating lung cancer, despite high incidence of
RT-induced cardiac complications. Most lung cancer patients present with
cardiac risk factors that result in compromised baseline cardiac function that
puts the patients at higher risk of developing cardiac complications. In this
study, we investigate characteristics of baseline cardiovascular function in
lung cancer patients undergoing RT. The results showed that the patients had borderline
cardiac function and reduced myocardial strain measurements. Myocardial T1/T2
values in the patients were slightly high and the hemodynamic measurements showed
different pattern than that in volunteers.
Introduction
Lung cancer is currently the leading cause of
cancer-related death. Along with systemic therapies, radiation therapy (RT)
plays a key role in treating lung cancer, although the incidence of RT-induced
cardiac complications could be as high as 33%. Interestingly, many trials have
not been able to correlate early deaths with clinically evident cardiotoxicity,
suggesting that early non-cancer deaths may be partially due to subclinical
cardiac dysfunction. Furthermore, most lung cancer patients present with cardiac
risk factors that result in compromised baseline cardiac function and put the
patients at higher risk of developing cardiac complications post-RT. Nevertheless,
the characteristics of baseline cardiovascular function in this patient
population are not well elucidated. In this study, we investigate these
characteristics in lung cancer patients undergoing RT.Methods
In this IRB-approved study, six patients diagnosed with lung cancer
and scheduled for RT underwent a comprehensive optimized MRI exam that included
cine, tagging, T1/T2 mappings, and 4D flow sequences. Optimized parameters for
cine imaging were: FIESTA acquisition, repetition time (TR) = 3.6 ms, echo time
(TE) = 1.3 ms, flip angle = 55°, views per segment = 14, # averages = 1, matrix
= 256×256, slice thickness = 8 mm, and readout bandwidth = 488 Hz/pixel.
Optimized parameters for tagged imaging were: TR= 5.7 ms, TE = 3.1 ms, flip
angle = 8°, slice thickness = 7mm, matrix = 212×192, FOV= 360×360 mm2,
# averages = 1, readout bandwidth = 391 Hz/pixel, tag spacing = 7 mm. Optimized
parameters for T1 mapping were: 5(3)3 MOLLI sequence, FIESTA acquisition, TR =
2:9 ms, TE = 1:3 ms, flip angle = 35°, slice thickness = 8 mm,
matrix = 160×148, FOV = 360×360 mm2, # averages = 1, and readout
bandwidth = 977 Hz/pixel. Optimized parameters for T2 mapping were: multi-echo
spin-echo sequence, TR = 895 ms, TE = 11 − 77 ms
(4 echoes with 22 ms increments), echo train length (ETL) = 16, flip angle =
90°, slice thickness = 8 mm, matrix = 180×180, FOV = 360×360 mm2, #
averages = 1, readout
bandwidth = 651 Hz/pixel.
Optimized parameters for 4D flow were: 3D time-resolved gradient echo sequence,
3 slabs with 32 slices per slab, and 5 overlapping slices between adjacent
slabs, matrix = 180×180, spatial resolution = 2 × 2 × 2:4 mm3,
views per segment = 4, number of heart phases = 20, flip angle = 8°, readout
bandwidth = 488 Hz/pixel, acceleration factor = 8, velocity encoding (venc) =
160 cm/s. The cine and T1/T2 images were analyzed using the cvi42 software to
measure ventricular ejection fraction (EF) and T1/T2 maps, respectively. The 4D
flow images were analyzed using cvi42 4D flow module to measure flow and
velocity in the aorta, pulmonary artery, and mitral and tricuspid valves. The
tagged images were analyzed using the SinMod-based InTag software to measure
regional myocardial strain. The hemodynamic results were compared to those from
two healthy volunteers. Measurements are represented as mean±SEM. Student’s
t-test was used to compare measurements between patients and volunteers
(P<0.05 significant).Results
EF was normal in all patients (57±3%). All strain
measurements (Figure 1) were below normal range (peak systolic strain
absolute values <17%), except for the radial basal strain measurement.
Basal, mid-ventricular, and apical circumferential strains were -10±0.7%, -11±1.4%, -10±1.7%,
respectively. Basal, mid-ventricular, and apical longitudinal strains were -14±0.9%, -14±0.9%, -16±1.3%,
respectively. Basal, mid-ventricular, and apical radial strains were 19±5.6%, 15±3.8%, 15±4.5%,
respectively. Global myocardial T1 and T2 values in the patients were 1267±68 ms and 53±1.3 ms, respectively, which were slightly higher than those in
the volunteers (1233±156 ms and 48±1.2 ms), but the differences were
not statistically significant. Table 1 shows summary of hemodynamic
measurements in both patients and volunteers. Maximum flow in the ascending
aorta and main pulmonary artery in the patients were smaller than those in the
volunteers, while maximum flow in the descending and distal aorta and right
pulmonary artery in the patients were larger than those in the volunteers.
Velocity values at all measurement sites in the patients were lower than those
in the volunteers. The early-to-atrial filling ratios (E/A) measured through
the mitral and tricuspid valves in the patients (1.1±0.02 and 1.6±0.34)
were lower than those in the volunteers (2.2±0.51 and 1.9±0.2),
although differences were not statistically significant.Discussion and Conclusions
Cardiac
MRI is a valuable modality for comprehensive assessment of heart health in
cancer patients. Lung cancer patients undergoing RT have borderline cardiac
function and myocardial strain measurements below normal values at baseline.
Myocardial T1/T2 values in the patients are slightly high and the hemodynamic
measurements show different pattern than that in normal volunteers. Therefore, MRI-based
baseline cardiovascular condition should be taken into consideration as a
contributing factor in RT-induced cardiotoxicity and cardioprotective efforts. Acknowledgements
Study funded by Radiation Oncology Institute (ROI)References
1.
D
Hardy et al. Ann Oncol
2010;21:1825-33.
2.
K
Wang et al. J Clin Oncol 2017;35:1387-94.
3.
RT
Dess et al. J Clin Oncol 2017;35:1395-402.
4.
EH
Ibrahim. Heart Mechanics. MRI. CRC Press 2017.